Primary Category:
Treatment Protocols
Disease Category:
Adjuvant Breast, Breast
Status:
Open
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy
Eligible for screening study DCP 001
NCT#02954874
Site Delegation of Tasks Log required prior to registration of any patients.
